Fluid Biomed Closes $27-Million USD Series A to Fund Expanded Human Clinical Studies

The ReSolv™ stent is an investigational device. It is not approved or cleared by the US Food and Drug Administration (FDA) for commercial distribution. It is available only through authorized clinical investigations.